Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Chief Financial Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 234,527 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 2,000 · Balance 234,527 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2024 Filed Mar 21, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,304 | $15.82 | $52,260.69 |
DisclosureSEC source: 0001773751-24-000088 · wk-form4_1711062467.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,235 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.76 - $15.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:03 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000079 · wk-form4_1710885779.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,013 Underlying: Class A Common Stock · 18,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:03 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 52,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000079 · wk-form4_1710885779.xml · derivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,162 Underlying: Class A Common Stock · 52,395 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:03 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 38,864 | $14.63 | $568,580.32 |
DisclosureSEC source: 0001773751-24-000079 · wk-form4_1710885779.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,539 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:03 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 70,729 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000079 · wk-form4_1710885779.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 40,527 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 964,395 Underlying: Class A Common Stock · 40,527 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F5 · derivative.exercise_date: 25% of the options vested on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service with the Issuer. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 43,876 | $13.57 | $595,498.23 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,674 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.34 - $13.725. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,349 | $13.41 | $44,900.04 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,550 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.35 - $13.51. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,349 | $13.40 | $44,889.33 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 193,899 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.35 - $13.50. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 40,527 | $5.01 | $203,040.27 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 367,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000045 · wk-form4_1709327237.xml · derivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,809 Underlying: Class A Common Stock · 367,809 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 00:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 26,385 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000008 · wk-form4_1707870348.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,004,922 Underlying: Class A Common Stock · 26,385 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the options shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 00:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 31,363 | $10.03 | $314,639.89 |
DisclosureSEC source: 0001773751-24-000008 · wk-form4_1707870348.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,721 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.00 - $10.09. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 00:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 26,385 | $5.01 | $132,188.85 |
DisclosureSEC source: 0001773751-24-000008 · wk-form4_1707870348.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 00:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 8,509 | $10.03 | $85,344.42 |
DisclosureSEC source: 0001773751-24-000008 · wk-form4_1707870348.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 161,699 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.01 - $10.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 20, 2023 Filed Dec 21, 2023 21:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,392 | $8.58 | $29,108.79 |
DisclosureSEC source: 0001773751-23-000321 · wk-form4_1703192997.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170,208 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.52 - $8.69. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 20, 2023 Filed Dec 21, 2023 21:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,392 | $8.58 | $29,095.56 |
DisclosureSEC source: 0001773751-23-000321 · wk-form4_1703192997.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,600 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.52 - $8.63. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:56 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000308 · wk-form4_1703023004.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,347 Underlying: Class A Common Stock · 18,335 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:56 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 52,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000308 · wk-form4_1703023004.xml · derivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,557 Underlying: Class A Common Stock · 52,395 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:56 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 38,022 | $8.45 | $321,285.90 |
DisclosureSEC source: 0001773751-23-000308 · wk-form4_1703023004.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,992 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:56 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 70,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000308 · wk-form4_1703023004.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,349 | $7.62 | $25,506.99 |
DisclosureSEC source: 0001773751-23-000282 · wk-form4_1700688209.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,284 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $7.58 - $7.67. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,349 | $7.62 | $25,503.30 |
DisclosureSEC source: 0001773751-23-000282 · wk-form4_1700688209.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,633 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $7.58 - $7.67. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2023 Filed Sep 22, 2023 14:50 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,397 | $6.28 | $21,331.12 |
DisclosureSEC source: 0001773751-23-000259 · wk-form4_1695394229.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,982 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Read SEC document |
| September 20, 2023 Filed Sep 22, 2023 14:50 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,397 | $6.28 | $21,327.05 |
DisclosureSEC source: 0001773751-23-000259 · wk-form4_1695394229.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,379 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000248 · wk-form4_1695147058.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,682 Underlying: Class A Common Stock · 18,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 52,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000248 · wk-form4_1695147058.xml · derivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 523,952 Underlying: Class A Common Stock · 52,396 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 37,970 | $6.31 | $239,590.70 |
DisclosureSEC source: 0001773751-23-000248 · wk-form4_1695147058.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,776 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:11 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 70,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000248 · wk-form4_1695147058.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 22:21 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,698 | $6.92 | $46,319.35 |
DisclosureSEC source: 0001773751-23-000230 · wk-form4_1692742905.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,016 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.85 - $6.96. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:55 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000173 · wk-form4_1687294496.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,016 Underlying: Class A Common Stock · 18,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:55 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 52,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000173 · wk-form4_1687294496.xml · derivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 576,348 Underlying: Class A Common Stock · 52,395 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:55 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 38,028 | $8.80 | $334,646.40 |
DisclosureSEC source: 0001773751-23-000173 · wk-form4_1687294496.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,714 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:55 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 70,729 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000173 · wk-form4_1687294496.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| March 17, 2023 Filed Mar 20, 2023 21:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 13,100 | $9.79 | $128,249.00 |
DisclosureSEC source: 0001773751-23-000104 · wf-form4_167934608462884.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,013 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2022 by the Reporting Person. Read SEC document |
| March 17, 2023 Filed Mar 20, 2023 21:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,620 | $10.00 | $26,200.00 |
DisclosureSEC source: 0001773751-23-000104 · wf-form4_167934608462884.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,113 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2022 by the Reporting Person. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 209,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000093 · wf-form4_167908412016096.xml · derivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628,743 Underlying: Class A Common Stock · 209,580 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on March 15, 2023, and the remaining 75% of the Company RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified Company Quarterly Vesting Dates of March 15, June 15, September 15 and December 15 occurring thereafter. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on March 15, 2023, and the remaining 75% of the Company RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified Company Quarterly Vesting Dates of March 15, June 15, September 15 and December 15 occurring thereafter. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on March 15, 2023, and the remaining 75% of the Company RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified Company Quarterly Vesting Dates of March 15, June 15, September 15 and December 15 occurring thereafter. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 102,347 | $9.01 | $922,146.47 |
DisclosureSEC source: 0001773751-23-000093 · wf-form4_167908412016096.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,733 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 209,580 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000093 · wf-form4_167908412016096.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 110,928 | $0.00 Strike: $7.67 | $0.00 |
DisclosureSEC source: 0001773751-23-000044 · wf-form4_167787925317415.xml · derivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,928 Underlying: Class A Common Stock · 110,928 shares Expires 2033-03-01 F2 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 293,350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000044 · wf-form4_167787925317415.xml · derivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,350 Underlying: Class A Common Stock · 293,350 shares Expires not disclosed F1 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| March 01, 2023 Filed Mar 17, 2023 20:16 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 110,928 | $0.00 Strike: $11.53 | $0.00 |
DisclosureSEC source: 0001773751-23-000096 · wf-form4a_167908420589044.xml · derivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,928 Underlying: Class A Common Stock · 110,928 shares Expires 2033-03-01 F2 · derivative.exercise_price: The exercise price of the options awarded has been adjusted from the original filing due to administrative error. F3 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 17, 2023 20:16 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 293,350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000096 · wf-form4a_167908420589044.xml · derivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,350 Underlying: Class A Common Stock · 293,350 shares Expires not disclosed F1 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | PurchaseClass A Common Stock | 7,500 | $3.52 | $26,399.25 |
DisclosureSEC source: 0001773751-22-000127 · wf-form4_165333623316718.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 01:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantStock Option (right to buy) · Derivative | 1,031,307 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-22-000050 · wf-form4_164609979819366.xml · derivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,031,307 Underlying: Class A Common Stock · 1,031,307 shares Expires 2032-02-23 F2 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 01:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 838,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000050 · wf-form4_164609979819366.xml · derivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 838,323 Underlying: Class A Common Stock · 838,323 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the Vesting Commencement Date of March 15, 2022, and the remaining 75% of the Company RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with the Company. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the Vesting Commencement Date of March 15, 2022, and the remaining 75% of the Company RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with the Company. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the Vesting Commencement Date of March 15, 2022, and the remaining 75% of the Company RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.